Đang chuẩn bị liên kết để tải về tài liệu:
báo cáo khoa học: " TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?"
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines? | Globalization and Health BioMed Central Open Access Debate TRIPS the Doha declaration and paragraph 6 decision what are the remaining steps for protecting access to medicines Vanessa Bradford Kerry1 and Kelley Lee 2 Address 1Harvard Medical School 260 Longwood Avenue Boston MA 02115 USA and 2Centre on Global Change and Health London School of Hygiene Tropical Medicine Keppel Street London WC1E 7HT UK Email Vanessa Bradford Kerry - vkerry@gmail.com Kelley Lee - kelley.lee@lshtm.ac.uk Corresponding author Published 24 May 2007 Received 17 November 2006 Globalization and Health 2007 3 3 doi l0.ll86 l744-8603-3-3 Accepted 24 May 2007 This article is available from http www.globalizationandhealth.cOm content 3 1 3 2007 Kerry and Lee licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract_ Background The World Trade Organisation s Declaration on the TRIPS Agreement and Public Health known as the Doha Declaration of 2001 and subsequent Decision on the Interpretation of Paragraph 6 reached in 2003 affirmed the flexibilities available under the Agreement on Trade Related Property Rights TRIPS to member states seeking to protect public health. Despite these important clarifications the actual implementation of these measures to improve access to medicines remains uncertain. There are also concerns that so-called TRIPS-plus measures within many regional and bilateral trade agreements are further undermining the capacity of the poor to access affordable medicines. Methods The paper reviews policy debates among governments nongovernmental organisations and international organisations from 1995 and notably since 2003 surrounding access to medicines and .